188 related articles for article (PubMed ID: 6813024)
1. Apolipoprotein/lipid interactions: studies with synthetic polypeptides.
Sparrow JT; Gotto AM
CRC Crit Rev Biochem; 1982; 13(1):87-107. PubMed ID: 6813024
[TBL] [Abstract][Full Text] [Related]
2. Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.
Labeur C; Lins L; Vanloo B; Baert J; Brasseur R; Rosseneu M
Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):580-8. PubMed ID: 9102180
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipoproteins: apolipoprotein structure and function.
Mahley RW; Innerarity TL; Rall SC; Weisgraber KH
J Lipid Res; 1984 Dec; 25(12):1277-94. PubMed ID: 6099394
[TBL] [Abstract][Full Text] [Related]
4. Lipid-binding properties of synthetic peptide fragments of human apolipoprotein A-II.
Benetollo C; Lambert G; Talussot C; Vanloo E; Cauteren TV; Rouy D; Dubois H; Baert J; Kalopissis A; Denèfle P; Chambaz J; Brasseur R; Rosseneu M
Eur J Biochem; 1996 Dec; 242(3):657-64. PubMed ID: 9022694
[TBL] [Abstract][Full Text] [Related]
5. A review of the unique features of HDL apoproteins.
Pownall HJ; Morrisett JD; Sparrow JT; Smith LC; Shepherd J; Jackson RL; Gotto AM
Lipids; 1979 Apr; 14(4):428-34. PubMed ID: 220493
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A-II: chemical synthesis and biophysical properties of three peptides corresponding to fragments in the amino-terminal half.
Chen TC; Sparrow JT; Gotto AM; Morrisett JD
Biochemistry; 1979 Apr; 18(8):1617-22. PubMed ID: 218625
[TBL] [Abstract][Full Text] [Related]
7. Association of synthetic peptide fragments of human apolipoprotein A-I with phospholipids.
Vanloo B; Demoor L; Boutillon C; Lins L; Brasseur R; Baert J; Fruchart JC; Tartar A; Rosseneu M
J Lipid Res; 1995 Aug; 36(8):1686-96. PubMed ID: 7595090
[TBL] [Abstract][Full Text] [Related]
8. Phospholipid binding studies with synthetic apolipoprotein fragments.
Sparrow JT; Gotto AM
Ann N Y Acad Sci; 1980; 348():187-211. PubMed ID: 6772077
[No Abstract] [Full Text] [Related]
9. Apolipoprotein C-II39-62 activates lipoprotein lipase by direct lipid-independent binding.
MacPhee CE; Hatters DM; Sawyer WH; Howlett GJ
Biochemistry; 2000 Mar; 39(12):3433-40. PubMed ID: 10727238
[TBL] [Abstract][Full Text] [Related]
10. Synthetic model peptides for apolipoproteins. I. Design and properties of synthetic model peptides for the amphipathic helices of the plasma apolipoproteins.
Brasseur R; Vanloo B; Deleys R; Lins L; Labeur C; Taveirne J; Ruysschaert JM; Rosseneu M
Biochim Biophys Acta; 1993 Sep; 1170(1):1-7. PubMed ID: 8399322
[TBL] [Abstract][Full Text] [Related]
11. Structure of a biologically active fragment of human serum apolipoprotein C-II in the presence of sodium dodecyl sulfate and dodecylphosphocholine.
Storjohann R; Rozek A; Sparrow JT; Cushley RJ
Biochim Biophys Acta; 2000 Jul; 1486(2-3):253-64. PubMed ID: 10903476
[TBL] [Abstract][Full Text] [Related]
12. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.
Mendez AJ; Anantharamaiah GM; Segrest JP; Oram JF
J Clin Invest; 1994 Oct; 94(4):1698-705. PubMed ID: 7929849
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional properties of the 154-171 wild-type and variant peptides of human lecithin-cholesterol acyltransferase.
Peelman F; Goethals M; Vanloo B; Labeur C; Brasseur R; Vandekerckhove J; Rosseneu M
Eur J Biochem; 1997 Nov; 249(3):708-15. PubMed ID: 9395317
[TBL] [Abstract][Full Text] [Related]
14. [Apoproteins in dyslipoproteinemia (author's transl)].
Dewailly P
Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
[TBL] [Abstract][Full Text] [Related]
15. Conformation of human apolipoprotein C-I in a lipid-mimetic environment determined by CD and NMR spectroscopy.
Rozek A; Sparrow JT; Weisgraber KH; Cushley RJ
Biochemistry; 1999 Nov; 38(44):14475-84. PubMed ID: 10545169
[TBL] [Abstract][Full Text] [Related]
16. Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions.
Yamamoto M; Morita SY; Kumon M; Kawabe M; Nishitsuji K; Saito H; Vertut-Doï A; Nakano M; Handa T
Biochim Biophys Acta; 2003 Jun; 1632(1-3):31-9. PubMed ID: 12782148
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein and lipid abnormalities in uremic children on hemodialysis.
Ohta T; Matsuda I
Clin Chim Acta; 1985 Apr; 147(2):145-54. PubMed ID: 3921292
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of virus-induced cell fusion by apolipoprotein A-I and its amphipathic peptide analogs.
Srinivas RV; Venkatachalapathi YV; Rui Z; Owens RJ; Gupta KB; Srinivas SK; Anantharamaiah GM; Segrest JP; Compans RW
J Cell Biochem; 1991 Feb; 45(2):224-37. PubMed ID: 1647394
[TBL] [Abstract][Full Text] [Related]
19. Association of a model class A (apolipoprotein) amphipathic alpha helical peptide with lipid: high resolution NMR studies of peptide.lipid discoidal complexes.
Mishra VK; Anantharamaiah GM; Segrest JP; Palgunachari MN; Chaddha M; Sham SW; Krishna NR
J Biol Chem; 2006 Mar; 281(10):6511-9. PubMed ID: 16407255
[TBL] [Abstract][Full Text] [Related]
20. Helix-helix association of a lipid-bound amphipathic alpha-helix derived from apolipoprotein C-II.
MacPhee CE; Howlett GJ; Sawyer WH; Clayton AH
Biochemistry; 1999 Aug; 38(33):10878-84. PubMed ID: 10451384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
